D
Lexeo Therapeutics, Inc. LXEO
$4.85 $0.1853.97% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -26.10M -32.66M -25.92M -29.49M -21.24M
Total Depreciation and Amortization 510.00K 501.00K 521.00K 509.00K 496.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -285.00K 3.71M 3.48M 3.79M 2.85M
Change in Net Operating Assets -1.34M 6.73M -6.41M 7.38M -2.26M
Cash from Operations -27.22M -21.72M -28.33M -17.81M -20.15M
Capital Expenditure -108.00K -- 0.00 -83.00K -213.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -39.07M 15.60M -93.58M 0.00 -5.00K
Cash from Investing -39.17M 15.60M -93.58M -83.00K -218.00K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -122.00K -159.00K -116.00K -111.00K -74.00K
Issuance of Common Stock 80.00M 170.00K 6.31M 39.00K 6.67M
Repurchase of Common Stock -- -- -4.00K 0.00 -13.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -6.92M -- -6.29M -- -6.29M
Cash from Financing 72.96M 11.00K -97.00K -72.00K 291.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 6.57M -6.11M -122.01M -17.96M -20.08M